Japanese patients ( n = 1,363 ) with acute coronary syndrome undergoing percutaneous coronary intervention were randomized to either prasugrel ( 20/3 .75 mg ) or clopidogrel ( 300/75 mg ) , both in combination with aspirin ( 81-330 mg for the first dose and 81-100 mg/day thereafter ) , for 24-48 weeks .